Literature DB >> 21959957

Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study.

R M Anjana1, R Pradeepa, M Deepa, M Datta, V Sudha, R Unnikrishnan, A Bhansali, S R Joshi, P P Joshi, C S Yajnik, V K Dhandhania, L M Nath, A K Das, P V Rao, S V Madhu, D K Shukla, T Kaur, M Priya, E Nirmal, S J Parvathi, S Subhashini, R Subashini, M K Ali, V Mohan.   

Abstract

AIMS/HYPOTHESIS: This study reports the results of the first phase of a national study to determine the prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in India.
METHODS: A total of 363 primary sampling units (188 urban, 175 rural), in three states (Tamilnadu, Maharashtra and Jharkhand) and one union territory (Chandigarh) of India were sampled using a stratified multistage sampling design to survey individuals aged ≥ 20 years. The prevalence rates of diabetes and prediabetes were assessed by measurement of fasting and 2 h post glucose load capillary blood glucose.
RESULTS: Of the 16,607 individuals selected for the study, 14,277 (86%) participated, of whom 13,055 gave blood samples. The weighted prevalence of diabetes (both known and newly diagnosed) was 10.4% in Tamilnadu, 8.4% in Maharashtra, 5.3% in Jharkhand, and 13.6% in Chandigarh. The prevalences of prediabetes (impaired fasting glucose and/or impaired glucose tolerance) were 8.3%, 12.8%, 8.1% and 14.6% respectively. Multiple logistic regression analysis showed that age, male sex, family history of diabetes, urban residence, abdominal obesity, generalised obesity, hypertension and income status were significantly associated with diabetes. Significant risk factors for prediabetes were age, family history of diabetes, abdominal obesity, hypertension and income status. CONCLUSIONS/INTERPRETATIONS: We estimate that, in 2011, Maharashtra will have 6 million individuals with diabetes and 9.2 million with prediabetes, Tamilnadu will have 4.8 million with diabetes and 3.9 million with prediabetes, Jharkhand will have 0.96 million with diabetes and 1.5 million with prediabetes, and Chandigarh will have 0.12 million with diabetes and 0.13 million with prediabetes. Projections for the whole of India would be 62.4 million people with diabetes and 77.2 million people with prediabetes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21959957     DOI: 10.1007/s00125-011-2291-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  6 in total

1.  The Indian Council of Medical Research-India Diabetes (ICMR-INDIAB) study: methodological details.

Authors:  Ranjit Mohan Anjana; Rajendra Pradeepa; Mohan Deepa; Manjula Datta; Vasudevan Sudha; Ranjit Unnikrishnan; Lalith M Nath; Ashok Kumar Das; Sri Venkata Madhu; Paturi Vishnupriya Rao; Deepak Kumar Shukla; Tanvir Kaur; Mohammed K Ali; Viswanathan Mohan
Journal:  J Diabetes Sci Technol       Date:  2011-07-01

2.  Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India--the Chennai Urban Rural Epidemiology Study (CURES-17).

Authors:  V Mohan; M Deepa; R Deepa; C S Shanthirani; S Farooq; A Ganesan; M Datta
Journal:  Diabetologia       Date:  2006-03-29       Impact factor: 10.122

3.  High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey.

Authors:  A Ramachandran; C Snehalatha; A Kapur; V Vijay; V Mohan; A K Das; P V Rao; C S Yajnik; K M Prasanna Kumar; J D Nair
Journal:  Diabetologia       Date:  2001-09       Impact factor: 10.122

4.  Prevalence and risk factors of diabetes in a community-based study in North India: the Chandigarh Urban Diabetes Study (CUDS).

Authors:  P Ravikumar; A Bhansali; M Ravikiran; S Bhansali; R Walia; G Shanmugasundar; J S Thakur; S Kumar Bhadada; P Dutta
Journal:  Diabetes Metab       Date:  2010-12-30       Impact factor: 6.041

5.  The burden of diabetes and impaired glucose tolerance in India using the WHO 1999 criteria: prevalence of diabetes in India study (PODIS).

Authors:  S M Sadikot; A Nigam; S Das; S Bajaj; A H Zargar; K M Prasannakumar; A Sosale; C Munichoodappa; V Seshiah; S K Singh; A Jamal; K Sai; Y Sadasivrao; S S Murthy; D K Hazra; S Jain; S Mukherjee; S Bandyopadhay; N K Sinha; R Mishra; M Dora; B Jena; P Patra; K Goenka
Journal:  Diabetes Res Clin Pract       Date:  2004-12       Impact factor: 5.602

6.  Comparison of capillary whole blood versus venous plasma glucose estimations in screening for diabetes mellitus in epidemiological studies in developing countries.

Authors:  Miranda Priya; Ranjit Mohan Anjana; Rajendra Pradeepa; Ramamurthy Jayashri; Mohan Deepa; Anil Bhansali; Viswanathan Mohan
Journal:  Diabetes Technol Ther       Date:  2011-03-15       Impact factor: 6.118

  6 in total
  266 in total

1.  Adiponectin Genetic Variant and Expression Coupled with Lipid Peroxidation Reveal New Signatures in Diabetic Dyslipidemia.

Authors:  Kakali Ghoshal; Tanima Chatterjee; Subhankar Chowdhury; Sanghamitra Sengupta; Maitree Bhattacharyya
Journal:  Biochem Genet       Date:  2021-02-04       Impact factor: 1.890

2.  High prevalence of insulin resistance and occurrence prior to hyperinsulinemia threshold among people living with HIV in Pune, India.

Authors:  Ivan Marbaniang; Shashikala Sangle; Sonali Salvi; Vandana Kulkarni; Dhananjay Shere; Prasad Deshpande; Smita Nimkar; Amita Gupta; Vidya Mave
Journal:  Diabetes Metab Syndr       Date:  2019-04-13

3.  Association of recently identified type 2 diabetes gene variants with Gestational Diabetes in Asian Indian population.

Authors:  Sekar Kanthimathi; Manickam Chidambaram; Dhanasekaran Bodhini; Samuel Liju; Aruyerchelvan Bhavatharini; Ram Uma; Ranjit Mohan Anjana; Viswanathan Mohan; Venkatesan Radha
Journal:  Mol Genet Genomics       Date:  2017-02-11       Impact factor: 3.291

Review 4.  The nuances of atherogenic dyslipidemia in diabetes: focus on triglycerides and current management strategies.

Authors:  P C Manoria; H K Chopra; S K Parashar; A L Dutta; Brian Pinto; Ajit Mullasari; Samir Prajapati
Journal:  Indian Heart J       Date:  2013-11-25

5.  Vitamin D Status, Gender Differences, and Cardiometabolic Health Disparities.

Authors:  Dharambir K Sanghera; Bishwa R Sapkota; Christopher E Aston; Piers R Blackett
Journal:  Ann Nutr Metab       Date:  2017-03-18       Impact factor: 3.374

Review 6.  Emerging links between type 2 diabetes and Alzheimer's disease.

Authors:  Gumpeny R Sridhar; Gumpeny Lakshmi; Gumpeny Nagamani
Journal:  World J Diabetes       Date:  2015-06-10

Review 7.  Role of lifestyle factors in the epidemic of diabetes: lessons learnt from India.

Authors:  M Deepa; R M Anjana; V Mohan
Journal:  Eur J Clin Nutr       Date:  2017-04-19       Impact factor: 4.016

Review 8.  Prevalence of type 2 diabetes and its complications in India and economic costs to the nation.

Authors:  R Pradeepa; V Mohan
Journal:  Eur J Clin Nutr       Date:  2017-04-19       Impact factor: 4.016

Review 9.  Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.

Authors:  Yan Zheng; Sylvia H Ley; Frank B Hu
Journal:  Nat Rev Endocrinol       Date:  2017-12-08       Impact factor: 43.330

10.  Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice.

Authors:  Mahalingam Balakumar; Durai Prabhu; Chandrakumar Sathishkumar; Paramasivam Prabu; Namita Rokana; Ramesh Kumar; Srividhya Raghavan; Avinash Soundarajan; Sunita Grover; Virender Kumar Batish; Viswanathan Mohan; Muthuswamy Balasubramanyam
Journal:  Eur J Nutr       Date:  2016-10-18       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.